Trials / Completed
CompletedNCT00036075
Study Using CP-461 to Treat Advanced Prostate Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (planned)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether an investigational drug, CP-461, is safe and effective for the treatment of patients with prostate cancer and who have measurable disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CP-461 |
Timeline
- Start date
- 2001-08-01
- Completion
- 2005-12-01
- First posted
- 2002-05-08
- Last updated
- 2011-10-17
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00036075. Inclusion in this directory is not an endorsement.